GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the second quarter ended June 30, 2023. GE HealthCare President and CEO Peter Arduini said, “We are pleased with organic orders growth of 6% for…
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2023,…
Fisher & Paykel Healthcare Director Donal O’Dwyer has announced his intention to retire as a director of the company with effect from 31 December 2023. The company also announced it has appointed Graham McLean to the Board as a non-executive director…
Centene Corporation (NYSE: CNC) (“the Company”) announced today its financial results for the second quarter ended June 30, 2023. In summary, the 2023 second quarter results were as follows: Total revenues (in millions) $ 37,608 Premium and service revenues (in millions)…
Centene Corporation (NYSE: CNC) announced today that its Texas subsidiary, Superior HealthPlan (Superior), will continue to provide the aged, blind and disabled (ABD) population with healthcare coverage through the STAR+PLUS program. A new six-year contract, with a maximum of three additional two-year extensions,…
Siemens Healthineers has opened its new Innovation Center in Erlangen, Germany, in the heart of the regional medical technology research area known as Medical Valley. The focus is on open innovation by collaborating with external partner companies, start-ups and academic…
The global transcatheter heart valve market is estimated to witness substantial growth, reaching a projected value of US$ 15.14 Billion by 2030 at a robust compound annual growth rate (CAGR) of 12.73% from 2022 to 2030. Key Companies Mentioned: Over…
The global aneurysm clips market size is anticipated to reach USD 112.92 million by 2030, expanding at a CAGR of 7.36% from 2023 to 2030. The market is expected to grow due to the rising incidence of intracranial aneurysms, the…
The Global Gene Panel Market to 2028 report has been added to ResearchAndMarkets.com’s offering. The global gene panel market is poised for impressive growth during the forecast period, driven by the increasing prevalence of genetic disorders such as Down syndrome, sickle cell disease, Tay-Sachs…
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the completion of enrollment to the randomized, double-blind phase III ALTAIR clinical trial (JapicCTI-205363/NCT04457297). ALTAIR is the circulating tumor DNA (ctDNA)-guided treatment escalation arm of the CIRCULATE-Japan adaptive…
In a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s The Feinstein Institutes for Medical Research have successfully implanted microchips into the brain of a man living with paralysis, and have developed artificial intelligence (AI) algorithms to re-link his…
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter of 2023. Second Quarter 2023 Highlights…